Companies /Healthcare

Nano X Imaging Ltd

NASDAQ: NNOX Medical Devices
$0.32
▼ $0.01 (−2.17%) today
Markets open · 3:35pm ET

NNOX at a Glance

Valuation
Market cap
$25.4M
Profitability
Revenue (TTM)
$15.6M
EPS (TTM)
$-1.72
Price
52-week range
$0 – $5
Street target
$4.13
Earnings
Next report
Nov 19, 2026

Headquartered in 94 Shlomo Shmeltzer Road, Petah Tikva Fiscal year ends December NASDAQ: NNOX nanox.vision

About Nano-X Imaging

Nano-X Imaging Ltd (NASDAQ: NNOX) is an Israeli medical imaging technology company focused on expanding access to preventive healthcare through an integrated, end-to-end imaging and healthcare services platform. The company's ecosystem includes Nanox.ARC, a cost-effective 3D multi-source digital tomosynthesis imaging system; Nanox.AI, a suite of AI-based algorithms that augment interpretation of routine CT imaging to identify early signs of chronic disease; Nanox.CLOUD, a cloud-based platform for data management and imaging analytics; Nanox.MARKETPLACE and USARAD Holdings, which provide teleradiology and cardiology services; and Nanox Health IT, which delivers RIS, PACS, AI, dictation, and infrastructure solutions for healthcare workflows. The company operates three reportable segments: Imaging Systems (Nanox.ARC), Teleradiology Services (radiology services), and AI and Software Solutions. Nanox has received FDA clearance for multiple iterations of its Nanox.ARC system and obtained CE mark certification for marketing in Europe. The company is pre-profitability, has accumulated a deficit of $518.5 million since inception, and has disclosed substantial doubt about its ability to continue as a going concern. It is currently restructuring its South Korea chip manufacturing operations by transitioning to third-party partners and reducing headcount, and has raised post-quarter capital through registered direct offerings and ATM programs to extend its cash runway. Updated

NNOX Coverage

Frequently Asked Questions

What does Nano-X Imaging do?

Nano-X Imaging Ltd (NASDAQ: NNOX) is an Israeli medical imaging technology company focused on expanding access to preventive healthcare through an integrated, end-to-end imaging and healthcare services platform.

What is the NNOX stock price target?

The Wall Street consensus 12-month price target for NNOX is $4.13.